Tuesday, 11 February 2025
  
Login

Australia's most trusted
source of pharma news

Tuesday, 11 February 2025
Ascott/Nuevo
Ascott/Nuevo
Next Summit coming to Australia

One of the biggest global events on industry's calendar - the Next Pharma Summit - is coming to Australia for the first time, bringing together companies and their cross-functional teams.

Four drugs pushed to May meet
Top drugs listed for the PBAC's controversial March meeting now face a two-month delay
TODAY
Novo scores much anticipated first
For the first time, a weight-loss drug has been approved for a cardiovascular indication in Australia
TODAY
Biggest earning PBS newcomers
The drugs that first saw PBS reimbursement last year, and how much they brought in for pharma
10 February
Top pharma career then... crickets
High-flying global pharma leader reveals what really happens when you leave a top corporate role
7 February
BMS unveils US$2B in cost cuts
On top of US$1.5B in reductions announced just 10 months ago
7 February
Aussie pharma leadership AWOL?
Expert warns bosses are operating in survival mode with staff development the casualty
6 February
Boehringer
Boehringer
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (7)

Sales & Customer Relations (22)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (4)

Executive Roles (1)

Other (15)

Who's left pharma and who's back?
Comings and goings in pharma this month with a string of job announcements seeing some exit industry while others return
10 February
Aussies snap up ex-global leaders
International industry heavyweights, formerly from Pfizer and GSK, join promising Aussie venture
10 February
Govt drops PBS listings for women
After decades, reimbursement for menopausal hormone therapy and oral contraceptive pills... and just in time for the election
10 February
Lundbeck, MSD add new products
The TGA has ticked two new products. Which one has already been recommended by the PBAC?
10 February Approvals Action
First-in-class drug PBS debut
ICYMI: The most popular stories published this week, headed by a reimbursement milestone
7 February Your week in 5 Minutes
PBS grows by $550 million in Q4
Unlike previous surges, this one was not driven by a few booming drugs. So what's pushed up overall spend?
7 February
Govt in hot water over genomics
Good news story about genetic testing opens the doors to public anger at the Federal Govt over discrimination
7 February
'Most Admired' pharma named
Fortune has released its All-Stars list of World's Most Admired Companies. Who made the cut?
6 February
Look who's a Global Top Biller
2024 was a high-performance year for this top-gun specialist pharma recruiter
6 February
New treatment? Drs want this...
HCPs reveal exactly what they need from pharma when prescribing new treatments
6 February
AZ calls for Budget focus on reform
AstraZeneca calls for early diagnosis and faster access to approved medicines
6 February
Thriving pharma celebrates 5 years
Boss of private Aussie company reveals what's in store for 2025
5 February
Vantive launches in kidney care
CEO's swansong sees a major new company created in renal therapy
5 February
Two-thirds of big pharmas shrink
Yet a few pleased investors enough to grow the industry's total market cap
5 February
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.